Fisher and Paykel has announced the launch of its new 950 Heated Humidification System, which provides respiratory support in conjunction with invasive, non-invasive and Optiflow nasal high flow therapies.
This high-performance system is optimised for ease of use and helps to minimise condensate, consisting of a heater base plus new sensing technologies and consumable sets.
“Fisher and Paykel is launching its new 950 Heated Humidification System, which has been met with a positive response from clinicians.“
A successor to the market-leading Fisher and Paykel 850 system, the device recently completed 50,000 hours of clinical trials, with customer feedback showing that 81 percent rated it better than its predecessor, while 99 percent said it performed at least was well.
It is being made available in New Zealand and Australia this month, with launches in Canada and Europe to follow. The US release is dependent on securing regulatory approval for the device.
Lewis Gradon, the firm's managing director and chief executive officer, said: "The Fisher and Paykel 950 system is the result of many years' development work and we are pleased to be introducing this revolutionary new product to the market."
With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge skill and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.See all the latest jobs in Medical Devices